317 related articles for article (PubMed ID: 19120345)
1. CCL18 is expressed in patients with bullous pemphigoid and parallels disease course.
Günther C; Carballido-Perrig N; Kopp T; Carballido JM; Pfeiffer C
Br J Dermatol; 2009 Apr; 160(4):747-55. PubMed ID: 19120345
[TBL] [Abstract][Full Text] [Related]
2. Increased expression of eotaxin and its specific receptor CCR3 in bullous pemphigoid.
Frezzolini A; Teofoli P; Cianchini G; Barduagni S; Ruffelli M; Ferranti G; Puddu P; De Pita O
Eur J Dermatol; 2002; 12(1):27-31. PubMed ID: 11809592
[TBL] [Abstract][Full Text] [Related]
3. Serum chemokine profile in patients with bullous pemphigoid.
Nakashima H; Fujimoto M; Asashima N; Watanabe R; Kuwano Y; Yazawa N; Maruyama N; Okochi H; Kumanogoh A; Tamaki K
Br J Dermatol; 2007 Mar; 156(3):454-9. PubMed ID: 17300233
[TBL] [Abstract][Full Text] [Related]
4. Activation of blood coagulation in bullous pemphigoid: role of eosinophils, and local and systemic implications.
Marzano AV; Tedeschi A; Fanoni D; Bonanni E; Venegoni L; Berti E; Cugno M
Br J Dermatol; 2009 Feb; 160(2):266-72. PubMed ID: 18945300
[TBL] [Abstract][Full Text] [Related]
5. Both Th1 and Th2 chemokines are elevated in sera of patients with autoimmune blistering diseases.
Echigo T; Hasegawa M; Shimada Y; Inaoki M; Takehara K; Sato S
Arch Dermatol Res; 2006 Jun; 298(1):38-45. PubMed ID: 16583210
[TBL] [Abstract][Full Text] [Related]
6. High level of thymus and activation-regulated chemokine in blister fluid and sera of patients with bullous pemphigoid.
Kakinuma T; Wakugawa M; Nakamura K; Hino H; Matsushima K; Tamaki K
Br J Dermatol; 2003 Feb; 148(2):203-10. PubMed ID: 12588369
[TBL] [Abstract][Full Text] [Related]
7. Presence of interleukin 10 in the serum and blister fluid of patients with pemphigus vulgaris and pemphigoid.
Bhol KC; Rojas AI; Khan IU; Ahmed AR
Cytokine; 2000 Jul; 12(7):1076-83. PubMed ID: 10880254
[TBL] [Abstract][Full Text] [Related]
8. Interleukin-16 expression and release in bullous pemphigoid.
Frezzolini A; Cianchini G; Ruffelli M; Cadoni S; Puddu P; De Pità O
Clin Exp Immunol; 2004 Sep; 137(3):595-600. PubMed ID: 15320912
[TBL] [Abstract][Full Text] [Related]
9. Elevated expression of CD23 on peripheral blood B lymphocytes from patients with bullous pemphigoid: correlation with increased serum IgE.
Inaoki M; Sato S; Takehara K
J Dermatol Sci; 2004 Jun; 35(1):53-9. PubMed ID: 15194147
[TBL] [Abstract][Full Text] [Related]
10. Role of BP180NC16a-enzyme-linked immunosorbent assay (ELISA) in the diagnosis of bullous pemphigoid in China.
Feng S; Lin L; Jin P; Wu Q; Zhou W; Sang H; Shao C
Int J Dermatol; 2008 Jan; 47(1):24-8. PubMed ID: 18173596
[TBL] [Abstract][Full Text] [Related]
11. Bullous pemphigoid: interaction of interleukin 5, anti-basement membrane zone antibodies and eosinophils. A preliminary observation.
Engineer L; Bhol K; Kumari S; Razzaque Ahmed A
Cytokine; 2001 Jan; 13(1):32-38. PubMed ID: 11145840
[TBL] [Abstract][Full Text] [Related]
12. Serum levels of BAFF are increased in bullous pemphigoid but not in pemphigus vulgaris.
Asashima N; Fujimoto M; Watanabe R; Nakashima H; Yazawa N; Okochi H; Tamaki K
Br J Dermatol; 2006 Aug; 155(2):330-6. PubMed ID: 16882171
[TBL] [Abstract][Full Text] [Related]
13. CC chemokine ligand-5 (CCL5/RANTES) and CC chemokine ligand-18 (CCL18/PARC) are specific markers of refractory unstable angina pectoris and are transiently raised during severe ischemic symptoms.
Kraaijeveld AO; de Jager SC; de Jager WJ; Prakken BJ; McColl SR; Haspels I; Putter H; van Berkel TJ; Nagelkerken L; Jukema JW; Biessen EA
Circulation; 2007 Oct; 116(17):1931-41. PubMed ID: 17909104
[TBL] [Abstract][Full Text] [Related]
14. Increased serum levels of a proliferation-inducing ligand in patients with bullous pemphigoid.
Watanabe R; Fujimoto M; Yazawa N; Nakashima H; Asashima N; Kuwano Y; Tada Y; Maruyama N; Okochi H; Tamaki K
J Dermatol Sci; 2007 Apr; 46(1):53-60. PubMed ID: 17250993
[TBL] [Abstract][Full Text] [Related]
15. Novel monoclonal antibodies detect elevated levels of the chemokine CCL18/DC-CK1 in serum and body fluids in pathological conditions.
van der Voort R; Kramer M; Lindhout E; Torensma R; Eleveld D; van Lieshout AW; Looman M; Ruers T; Radstake TR; Figdor CG; Adema GJ
J Leukoc Biol; 2005 May; 77(5):739-47. PubMed ID: 15713699
[TBL] [Abstract][Full Text] [Related]
16. Increased CCL18 expression in patients with cutaneous T-cell lymphoma: association with disease severity and prognosis.
Miyagaki T; Sugaya M; Suga H; Ohmatsu H; Fujita H; Asano Y; Tada Y; Kadono T; Sato S
J Eur Acad Dermatol Venereol; 2013 Jan; 27(1):e60-7. PubMed ID: 22404649
[TBL] [Abstract][Full Text] [Related]
17. Evaluation of a BP180-NC16a enzyme-linked immunosorbent assay in the initial diagnosis of bullous pemphigoid.
Sakuma-Oyama Y; Powell AM; Oyama N; Albert S; Bhogal BS; Black MM
Br J Dermatol; 2004 Jul; 151(1):126-31. PubMed ID: 15270881
[TBL] [Abstract][Full Text] [Related]
18. Disturbances of the expression of metalloproteinases and their tissue inhibitors cause destruction of the basement membrane in pemphigoid.
Narbutt J; Waszczykowska E; Lukamowicz J; Sysa-Jedrzejowska A; Kobos J; Zebrowska A
Pol J Pathol; 2006; 57(2):71-6. PubMed ID: 17019968
[TBL] [Abstract][Full Text] [Related]
19. Correlation of IgE autoantibody to BP180 with a severe form of bullous pemphigoid.
Iwata Y; Komura K; Kodera M; Usuda T; Yokoyama Y; Hara T; Muroi E; Ogawa F; Takenaka M; Sato S
Arch Dermatol; 2008 Jan; 144(1):41-8. PubMed ID: 18209167
[TBL] [Abstract][Full Text] [Related]
20. Increased expression of CC chemokine ligand 18 in extrinsic atopic dermatitis patients.
Park CO; Lee HJ; Lee JH; Wu WH; Chang NS; Hua L; Lee MG; Lee KH
Exp Dermatol; 2008 Jan; 17(1):24-9. PubMed ID: 17979978
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
